346 related articles for article (PubMed ID: 37159031)
1. Diagnosis and Management of Cirrhosis and Its Complications: A Review.
Tapper EB; Parikh ND
JAMA; 2023 May; 329(18):1589-1602. PubMed ID: 37159031
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertension.
Turco L; Reiberger T; Vitale G; La Mura V
Liver Int; 2023 Jun; 43(6):1183-1194. PubMed ID: 36897563
[TBL] [Abstract][Full Text] [Related]
3. Presentation and complications associated with cirrhosis of the liver.
Poordad FF
Curr Med Res Opin; 2015 May; 31(5):925-37. PubMed ID: 25697811
[TBL] [Abstract][Full Text] [Related]
4. Complications of cirrhosis.
Rahimi RS; Rockey DC
Curr Opin Gastroenterol; 2012 May; 28(3):223-9. PubMed ID: 22343347
[TBL] [Abstract][Full Text] [Related]
5. AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review.
Garcia-Tsao G; Abraldes JG; Rich NE; Wong VW
Gastroenterology; 2024 Jan; 166(1):202-210. PubMed ID: 37978969
[TBL] [Abstract][Full Text] [Related]
6. Update in the Treatment of the Complications of Cirrhosis.
Abraldes JG; Caraceni P; Ghabril M; Garcia-Tsao G
Clin Gastroenterol Hepatol; 2023 Jul; 21(8):2100-2109. PubMed ID: 36972759
[TBL] [Abstract][Full Text] [Related]
7. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
Lv Y; Yang Z; Liu L; Li K; He C; Wang Z; Bai W; Guo W; Yu T; Yuan X; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Cai H; Xia J; Yin Z; Wu K; Fan D; Han G;
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):587-598. PubMed ID: 31153882
[TBL] [Abstract][Full Text] [Related]
8. Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.
Frenette C; Kayali Z; Mena E; Mantry PS; Lucas KJ; Neff G; Rodriguez M; Thuluvath PJ; Weinberg E; Bhandari BR; Robinson J; Wedick N; Chan JL; Hagerty DT; Kowdley KV;
J Hepatol; 2021 Feb; 74(2):274-282. PubMed ID: 33038432
[TBL] [Abstract][Full Text] [Related]
9. Cirrhosis and its complications: evidence based treatment.
Nusrat S; Khan MS; Fazili J; Madhoun MF
World J Gastroenterol; 2014 May; 20(18):5442-60. PubMed ID: 24833875
[TBL] [Abstract][Full Text] [Related]
10. Outpatient management of cirrhosis: a narrative review.
Mathews RE; McGuire BM; Estrada CA
South Med J; 2006 Jun; 99(6):600-6. PubMed ID: 16800415
[TBL] [Abstract][Full Text] [Related]
11. Management of patients with complications of cirrhosis.
Fowler C
Nurse Pract; 2013 Apr; 38(4):14-21; quiz 22-3. PubMed ID: 23454902
[TBL] [Abstract][Full Text] [Related]
12. [Current status and perspectives of diagnosis and treatment of complications related to liver cirrhosis].
Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):241-245. PubMed ID: 28494539
[TBL] [Abstract][Full Text] [Related]
13. Current and future pharmacological therapies for managing cirrhosis and its complications.
Kockerling D; Nathwani R; Forlano R; Manousou P; Mullish BH; Dhar A
World J Gastroenterol; 2019 Feb; 25(8):888-908. PubMed ID: 30833797
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.
Zacharias AP; Jeyaraj R; Hobolth L; Bendtsen F; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011510. PubMed ID: 30372514
[TBL] [Abstract][Full Text] [Related]
15. Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
Ripoll C; Platzer S; Franken P; Aschenbach R; Wienke A; Schuhmacher U; Teichgräber U; Stallmach A; Steighardt J; Zipprich A;
Trials; 2023 Apr; 24(1):258. PubMed ID: 37020315
[TBL] [Abstract][Full Text] [Related]
16. Current status of liver diseases in Korea: liver cirrhosis.
Jang JW
Korean J Hepatol; 2009 Dec; 15 Suppl 6():S40-9. PubMed ID: 20037279
[TBL] [Abstract][Full Text] [Related]
17. Different patterns of decompensation in patients with alcoholic vs. non-alcoholic liver cirrhosis.
Wiegand J; Kühne M; Pradat P; Mössner J; Trepo C; Tillmann HL
Aliment Pharmacol Ther; 2012 Jun; 35(12):1443-50. PubMed ID: 22530565
[TBL] [Abstract][Full Text] [Related]
18. Cirrhosis and chronic liver failure: part II. Complications and treatment.
Heidelbaugh JJ; Sherbondy M
Am Fam Physician; 2006 Sep; 74(5):767-76. PubMed ID: 16970020
[TBL] [Abstract][Full Text] [Related]
19. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
Villanueva C; Albillos A; Genescà J; Garcia-Pagan JC; Calleja JL; Aracil C; Bañares R; Morillas RM; Poca M; Peñas B; Augustin S; Abraldes JG; Alvarado E; Torres F; Bosch J
Lancet; 2019 Apr; 393(10181):1597-1608. PubMed ID: 30910320
[TBL] [Abstract][Full Text] [Related]
20. End-stage liver disease complications.
Rahimi RS; Rockey DC
Curr Opin Gastroenterol; 2013 May; 29(3):257-63. PubMed ID: 23429468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
